Featured Article
Adenoma
By prostate Doc at 21 August, 2008, 4:02 pm
The most common neoplasm of renal tubular epithelium are papillary adenoma. These lesions are usually discovered during autopsy with a frequency between 7 and 22%. They are located in the renal cortex and are typically <1 cm in size.
Latest Articles
Combined Androgen Blockade : Prostate
By prostate Doc at 7 October, 2008, 6:58 pm
It was proposed in the 1980s that testicular androgen deprivation combined with an antiandrogen would be superior to testicular androgen deprivation alone. This is referred to as combined androgen blockade (CAB) or maximal androgen blockade (MAB).
Read More >>Etiology and Clinical Factors : Prostate cancer
By prostate Doc at 6 October, 2008, 1:58 pm
Etiology
Epidemiologic factors associated with the development of prostate cancer in- clude age, genetic background, race, hormone status, and suspected dietary factors. Prostate cancer appears to be age-related occurring in 30% of men over age 50, and 80% of men over age 80, with an increase in incidence in each decade. It is impor- tant to [...]
Survival : Prostate cancer
By prostate Doc at 6 October, 2008, 12:53 pm
Since prostate cancer is a slow growing tumor, it is pertinent to look at survival after treatment at the 5- to 15-year period. Most data for survival appears favorable at the 5-year mark, but declines before 10 years. In general, about 70% of men treated by radical prostatectomy are cured. Approximately 20% of men will [...]
Read More >>Prostate Surgery
By prostate Doc at 29 September, 2008, 5:44 pm
Prostatectomy for Cure
Selection of candidates suitable for surgery is based on the natural history of prostate cancer, its Gleason score, the life expectancy of the candidate, and consideration of morbidity from the operation. The best candidates for total prostatectomy are those likely to benefit from it, and therefore, they should be young enough to [...]
Chemotherapy of Hormone Refractory Disease
By prostate Doc at 23 September, 2008, 7:43 pm
Historically, hormone refractory prostate cancer has been viewed as a condition minimally responsive to cytotoxic agents. This view is largely based on data generated before the mid-1990s using single agents or combinations of drugs. Doxorubicin, cyclophosphamide, vinblastine, cisplatin, fluorouracil, mitoxantrone, and estramustine have all been shown to have objective response rates <15%.
Read More >>